Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 70.50
+0.40 (0.57%)
Dec 31, 2025, 12:08 PM HKT
Xuanzhu Biopharmaceutical Revenue
Xuanzhu Biopharmaceutical had revenue of 17.89M CNY in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 31.96M. In the year 2024, Xuanzhu Biopharmaceutical had annual revenue of 30.09M with 103,672.41% growth.
Revenue (ttm)
31.96M CNY
Revenue Growth
+103,672.41%
P/S Ratio
1,042.76
Revenue / Employee
80.70K CNY
Employees
396
Market Cap
36.52B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.09M | 30.07M | 103,672.41% |
| Dec 31, 2023 | 29.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.69B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 33.49B |
| CSPC Pharmaceutical Group | 28.65B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |